Christina Yeni Kustanti

Dr. Christina Yeni Kustanti

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
HCHsin Chu
Hsin Chu
XKXiao Linda Kang
Xiao Linda Kang
DLDoresses Liu
Doresses Liu
LPLi-Chung Pien
Li-Chung Pien
KCKuei-Ru Chou
Kuei-Ru Chou

30 June 2023 in Journal of Global Health
Verified
Journal Article
Open access
CSChien-Mei Sung
Chien-Mei Sung
HJHsiu-Ju Jen
Hsiu-Ju Jen
DLDoresses Liu
Doresses Liu
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
HCHsin Chu
Hsin Chu
KCKuei-Ru Chou
Kuei-Ru Chou
Population aging is a key global issue today. Besides visible changes in the aging process, the cognitive neural functions of elderly individuals have been targeted as needing attention. Multiple aspects of their abilities decline, including neural structure (gray and white matter), functionality, neurotransmitter reduction, processing speed, attention, memory, and visual-spatial abilities. This affects not only […]

28 June 2024 in Journal of Global Health
Verified
Journal Article
Open access
CLChiao-Ling Lin
Chiao-Ling Lin
RCRuey Chen
Ruey Chen
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
HCHsin Chu
Hsin Chu
CLChiu-Kuei Lee
Chiu-Kuei Lee
KCKuei-Ru Chou
Kuei-Ru Chou
The projection for the global population aged ≥60 years will increase from 1.4 billion to 2.1 billion between 2030 and 2050 [1]. Internationally, the increase in the elderly population from 7 to 14% signifies the pace of societal aging. Compared to other countries, France has undergone a gradual aging process over 115 years, while Sweden […]

19 June 2024 in BioImpacts
Verified
Journal Article
Open access
PDF file
IRIka Rahayu
Ika Rahayu
NANur Arfian
Nur Arfian
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
MWMae Sri Hartati Wahyuningsih
Mae Sri Hartati Wahyuningsih
Introduction: Oxidative stress plays a central role in the pathophysiology of diabetes mellitus and its complications, including diabetic nephropathy. Excessive production of reactive oxygen species (ROS) alters renal metabolic pathways, leading to inflammation, endothelial dysfunction, and fibrosis, ultimately resulting in end-stage renal disease (ESRD). Studies have shown that exogenous antioxidants can improve the pathophysiological condition of patients with diabetic nephropathy. Objective: This systematic review aims to investigate the types of antioxidant agents that inhibit the development of diabetic nephropathy and the effectiveness of antioxidant agent interventions to repair kidney structure and function. Methods: A systematic review of randomized controlled trials that examined the role of antioxidants in improving diabetic nephropathy was conducted. The literature search was performed on PubMed, ScienceDirect, and EBSCO. The inclusion criteria covered articles on the antioxidant activity of herbal extracts and compounds that inhibit the progression of diabetic nephropathy in humans. In addition, the articles were written in English and published between 2012 and 2022. The reporting of the systematic review followed the Preferred Reporting Elements for Systematic Review and Meta-Analysis (PRISMA) guideline. The full texts of all potentially relevant systematic reviews were assessed for quality using the Risk of Bias 2 (RoB 2) tool. Results: A total of 2,367 articles were identified in the three databases, of which only 15 articles met the inclusion criteria. Antioxidant agents that inhibit diabetic nephropathy can be classified as single antioxidants (silymarin, baicalin, epigallocatechin gallate, vitamin E, selenium, curcumin, α-lipoic acid, and tocotrienol-rich vitamin E) and combined antioxidants (α-lipoic acid with vitamin B6, and resveratrol with losartan). Antioxidant agents have been shown to reduce oxidative stress and inflammation, but their role in the progression of fibrosis remains unclear. The oxidative stress marker MDA was significantly reduced by silymarin, curcumin, vitamin E, tocotrienol-rich vitamin E, selenium, ALA, vitamin B, resveratrol and losartan. Silymarin was found to be the most effective (-3.43 µmol/L; 6.02 to 0.83). Compared to silymarin and epigallocatechin gallate, vitamin E was more effective (at -35.4 ng/L; P < 0.001) in reducing inflammation by decreasing TNF-α levels. In addition, tocotrienol-rich vitamin E, silymarin, baicalin, and selenium showed a decrease TGF-β levels, but did not show statistically significant differences between the placebo and intervention groups. Conclusion: Potential antioxidant agents, such as flavonoids, vitamins, fatty acids, and antioxidant minerals, were examined in this systematic review. These agents contribute to reducing markers of oxidative stress and hyperglycemia-induced inflammation. Although several antioxidants play a role in reducing fibrosis markers, the effect does not appear to be statistically significant.

9 July 2025 in International Journal of Mental Health Nursing
Verified
Journal Article
Closed access
RSRika Sarfika
Rika Sarfika
HMHema Malini
Hema Malini
BWBunga Permata Wenny
Bunga Permata Wenny
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
ISI. Made Moh. Yanuar Saifudin
I. Made Moh. Yanuar Saifudin
Ferry EfendiFerry Efendi
Ferry Efendi

30 March 2025 in Psychiatry Research
Verified
Journal Article
Closed access
Christina Yeni KustantiChristina Yeni Kustanti
Christina Yeni Kustanti
RSRika Sarfika
Rika Sarfika
Ferry EfendiFerry Efendi
Ferry Efendi
KAKhatijah Lim Abdullah
Khatijah Lim Abdullah
EKErik Adik Putra Bambang Kurniawan
Erik Adik Putra Bambang Kurniawan
WPWulandari Pratiwi
Wulandari Pratiwi